Trials / Completed
CompletedNCT04099173
A Brief Mindfulness-Based Intervention for Suicidal Ideation
A Randomized Pilot Study of a Brief Mindfulness-Based Intervention for Suicidal Ideation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- VA Salt Lake City Health Care System · Federal
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this study is to determine whether a Brief Mindfulness-Based Intervention for Suicidal Ideation (MB-SI) is feasible and safe to implement. The secondary aims are short and longer-term reduction in suicidal ideation (SI) and/or suicide-related behaviors (SRBs) as well as improvements in mindfulness and emotional regulation measures compared to Treatment as Usual (TAU).
Detailed description
The study feasibility will be assessed through participant enrollment and retention numbers. The safety be monitored by the study personnel and include reporting any adverse effects. The intervention fidelity will be aided by standardizing the intervention and ensuring study personnel has the appropriate trainings. Participants will completed questionnaires assessing their SI and SRB as well as mindfulness and emotional regulation measures at three time points (preintervention, immediately postintervention, and 1-month postintervention) and their results will be compared between MB-SI and TAU groups. Additionally, the comparisons will also be conducted for the Emergency Department (ED) admissions, Inpatient Psychiatric Unit (IPU) admissions, and psychiatric ED admissions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Brief Mindfulness Based Intervention | This intervention will consist of four, 45 minute individual mindfulness training sessions (one session per day, over a range of 12 subsequent days) provided by a trained mindfulness facilitator. |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2023-01-05
- Completion
- 2023-01-05
- First posted
- 2019-09-23
- Last updated
- 2023-05-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04099173. Inclusion in this directory is not an endorsement.